Genomic rearrangement of TMPRSS2 fusions with oncogenic ETS factors: Evidence of epigenetic programming of potential therapeutic significance in prostate cancer

被引：0
|
作者：
Gupta, Santosh K. [1 ]
Wol, Maija [1 ]
Ljlin, Ktsitiina [1 ]
Nees, Matthias [1 ]
Kallioniemi, Olli [1 ]
机构：
[1] Univ Turku, SF-20500 Turku, Finland
来源：
CELLULAR ONCOLOGY | 2008年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [31] Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors
    McGrath, Colleen B.
    Shreves, Alaina H.
    Shanahan, Megan R.
    Guard, Hannah E.
    Nhliziyo, Manelisi V.
    Penney, Kathryn L.
    Lotan, Tamara L.
    Fiorentino, Michelangelo
    Stopsack, Konrad H.
    Mucci, Lorelei A.
    CANCER RESEARCH, 2024, 84 (06)
  • [32] A transgenic mouse model of a common genetic aberration in prostate cancer: Chromosomal rearrangement of TMPRSS2:ERG
    Casey, Orla M.
    Awwad, Hibah
    Zhang, Luhua
    Fang, Lei
    Hynes, Paul G.
    Abou-Kheir, Wassim G.
    Martin, Philip
    Kelly, Kathleen
    CANCER RESEARCH, 2010, 70
  • [33] TMPRSS2:ERG Gene Fusions in Prostate Cancer of West African Men and a Meta-Analysis of Racial Differences
    Zhou, Cindy Ke
    Young, Denise
    Yeboah, Edward D.
    Coburn, Sally B.
    Tettey, Yao
    Biritwum, Richard B.
    Adjei, Andrew A.
    Tay, Evelyn
    Niwa, Shelley
    Truelove, Ann
    Welsh, Judith
    Mensah, James E.
    Hoover, Robert N.
    Sesterhenn, Isabell A.
    Hsing, Ann W.
    Srivastava, Shiv
    Cook, Michael B.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2017, 186 (12) : 1352 - 1361
  • [34] The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
    Pettersson, Andreas
    Graff, Rebecca E.
    Bauer, Scott R.
    Pitt, Michael J.
    Lis, Rosina T.
    Stack, Edward C.
    Martin, Neil E.
    Kunz, Lauren
    Penney, Kathryn L.
    Ligon, Azra H.
    Suppan, Catherine
    Flavin, Richard
    Sesso, Howard D.
    Rider, Jennifer R.
    Sweeney, Christopher
    Stampfer, Meir J.
    Fiorentino, Michelangelo
    Kantoff, Philip W.
    Sanda, Martin G.
    Giovannucci, Edward L.
    Ding, Eric L.
    Loda, Massimo
    Mucci, Lorelei A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (09) : 1497 - 1509
  • [35] Gene fusions between TMPRSS2 and ETS family genes in prostate cancer:: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues
    Tu, Jiangling J.
    Rohan, Stephen
    Kao, Jean
    Kitabayashi, Naoki
    Mathew, Susan
    Chen, Yao-Tseng
    MODERN PATHOLOGY, 2007, 20 (09) : 921 - 928
  • [36] TMPRSS2:ERG Fusion Positive and TMPRSS2:ERG Wild Type Relapsed and Metastatic Castrate Resistant Prostate Cancer Differ in Genomic Signatures and Opportunities for Targeted and Immunotherapies
    Gay, Laurie
    Chung, Jon
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Severson, Eric
    Ramkissoon, Shakti
    Daniel, Sugganth
    Ali, Siraj
    Frampton, Garrett M.
    Hartmaier, Ryan
    Albacker, Lee
    Schrock, Alexa B.
    Miller, Vincent A.
    Stephens, Philip M.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2018, 31 : 341 - 342
  • [37] TMPRSS2: ERG Fusion Positive and TMPRSS2: ERG Wild Type Relapsed and Metastatic Castrate Resistant Prostate Cancer Differ in Genomic Signatures and Opportunities for Targeted and Immunotherapies
    Gay, Laurie
    Chung, Jon
    Elvin, Julia A.
    Vergilio, Jo-Anne
    Suh, James
    Severson, Eric
    Ramkissoon, Shakti
    Daniel, Sugganth
    Ali, Siraj
    Frampton, Garrett M.
    Hartmaier, Ryan
    Albacker, Lee
    Schrock, Alexa B.
    Miller, Vincent A.
    Stephens, Philip M.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2018, 98 : 341 - 342
  • [38] Transcriptional Regulation of CXCR4 in Prostate Cancer: Significance of TMPRSS2-ERG Fusions
    Singareddy, Rajareddy
    Semaan, Louie
    Conley-LaComb, M. Katie
    St John, Jason
    Powell, Katelyn
    Iyer, Matthew
    Smith, Daryn
    Heilbrun, Lance K.
    Shi, Dongping
    Sakr, Wael
    Cher, Michael L.
    Chinni, Sreenivasa R.
    MOLECULAR CANCER RESEARCH, 2013, 11 (11) : 1349 - 1361
  • [39] Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion-positive prostate cancer
    Yun, Jae Won
    Lee, Sejoon
    Chun, Sejong
    Lee, Kwang Woo
    Kim, Jongsu
    Kim, Hong Sook
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (05):
  • [40] CASTRATE RESISTANT TMPRSS2: ERG FUSION POSITIVE AND TMPRSS2: ERG WILD TYPE REFRACTORY ACINAR AND NEUROENDOCRINE PROSTATE CANCER DIFFER IN GENOMIC SIGNATURES AND OPPORTUNITIES FOR TARGETED AND IMMUNOTHERAPIES
    Liu, Nick
    Fisher, Hugh A. G.
    Byler, Timothy
    Jacob, Joseph
    Chung, Jon
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Ramkissoon, Shakti
    Suh, James
    Severson, Eric Allan
    Daniel, Sugganth
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Kotula, Leszek
    Ross, Jeffrey S.
    Bratslavsky, Gennady
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1145 - E1146
12345